Valuation: Takeda Pharmaceutical Company Limited

Market Cap 9,336B 60.2B 52.17B 49.31B 44.76B 83.9B 5,775B 84.4B 589B 227B 2,929B 226B 221B P/E 2027 *
46.3x
P/E 2028 * 29.4x
Enterprise Value 13,243B 85.39B 73.99B 69.94B 63.49B 119B 8,191B 120B 835B 323B 4,155B 321B 314B EV / Sales 2027 *
2.82x
EV / Sales 2028 * 2.73x
Free-Float
99.26%
Yield 2027 *
3.49%
Yield 2028 * 3.56%
1 day+1.69%
1 week+5.11%
Current month+3.14%
1 month+7.85%
3 months+20.41%
6 months+2.16%
Current year+22.98%
1 week 5,557
Extreme 5557
5,947
1 month 5,504
Extreme 5504
5,947
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 56 31/12/2024
Director of Finance/CFO 48 31/03/2024
Chief Tech/Sci/R&D Officer 47 31/01/2022
Director TitleAgeSince
Director/Board Member 60 31/05/2015
Director/Board Member 73 31/12/2018
Director/Board Member 48 31/05/2024
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Sell

Executive/Senior Manager

-34,535 0.0022%
02/09/26 Sell

Chief Technology Officer

-116,191 0.0073%
19/08/26 Sell

Chief Technology Officer

-19,651 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+1.69%+5.11%+34.22%+23.13% 60.2B
+0.15%+1.21%+48.79%+97.65% 1,014B
+0.03%+0.07%+51.47%+65.55% 644B
-0.20%+4.62%+21.39%+72.57% 464B
-0.90%+4.34%+38.44%+39.76% 354B
+0.43%+2.53%+19.05%+24.95% 265B
+0.76%+4.13%+7.44%+14.13% 253B
+0.19%-3.81%+37.81%+44.35% 203B
+0.34%-4.21%-25.78%-57.83% 186B
+0.94%+1.39%+33.21%+95.16% 183B
Average +0.35%+1.28%+26.60%+41.94% 362.7B
Weighted average by Cap. +0.13%+1.46%+34.22%+59.63%

Financials

2027 *2028 *
Net sales 4,701B 30.31B 26.27B 24.83B 22.54B 42.24B 2,908B 42.49B 296B 115B 1,475B 114B 111B 4,781B 30.83B 26.72B 25.25B 22.92B 42.97B 2,958B 43.22B 301B 116B 1,500B 116B 113B
Net income 196B 1.27B 1.1B 1.04B 942M 1.77B 122B 1.78B 12.39B 4.79B 61.65B 4.76B 4.65B 322B 2.08B 1.8B 1.7B 1.55B 2.9B 199B 2.91B 20.33B 7.86B 101B 7.81B 7.64B
Net Debt 3,907B 25.19B 21.83B 20.63B 18.73B 35.1B 2,416B 35.31B 246B 95.17B 1,226B 94.62B 92.52B 3,702B 23.87B 20.69B 19.55B 17.75B 33.27B 2,290B 33.47B 233B 90.19B 1,161B 89.67B 87.68B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
17/09/26 JP¥5,946.00 +1.69% 4,687,800
16/09/26 JP¥5,847.00 0.00% 3,811,500
15/09/26 JP¥5,847.00 +1.92% 4,665,400
14/09/26 JP¥5,737.00 +1.25% 2,846,900
11/09/26 JP¥5,666.00 +0.16% 4,255,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
5,847.00JPY
Average target price
6,603.31JPY
Spread / Average Target
+12.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!